Lazard Asset Management »

Arcus Biosciences Incorporated shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $93k 6.3k 14.85
2024-09-30 $2.0k 183 10.93
2024-06-30 $89k 5.9k 15.18
2023-09-30 $71k 4.0k 17.93
2022-12-31 $132k 6.4k 20.58
2022-09-30 $167k 6.4k 26.03
2022-06-30 $61k 2.4k 25.04
2022-03-31 $76k 2.4k 31.20
2020-12-31 $68k 2.6k 25.71

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Visa Common Stock (V)
Intercontinen Common Stock (ICE)
Bank Of America Common Stock (BAC)
Norfolk Souther Common Stock (NSC)
Broadcom Common Stock (AVGO)
Unitedhealth Gr Common Stock (UNH)
Exelon Corp Common Stock (EXC)
Accenture Common Stock (ACN)
Taiwan Semi- CommonStock ADR (TSM)
Aon Plc/ireland Common Stock (AON)
Thermo Fisher Common Stock (TMO)

View all positions for Lazard Asset Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
FMR
Woodline Partners
State Street Corporation
Point72 Asset Management
Dimensional Fund Advisors
Siren
Boxer Capital Management
Ameriprise Financial
Bnp Paribas Investment Partners
Parkman Healthcare Partners
Geode Capital Management
Millennium Management

View all funds holding Arcus Biosciences Incorporated